CYBERMED NEWS - Higher Medical Scientifc Information and Research

DR. STEFANO FAIS

Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect

Written by CYBERMED NEWS
Attachments:
Download this file (Luginiet al,JEIMC  2015.pdf)Luginiet al,JEIMC 2015.pdf[Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect]414 kB
facebook Share on Facebook

Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect

 

Abstract

CONTEXT:

Tumor acidity represents a major cause of chemoresistance. Proton pump inhibitors (PPIs) can neutralize tumor acidity, sensitizing cancer cells to chemotherapy.

OBJECTIVE:

To compare the anti-tumor efficacy of different PPIs in vitro and in vivo.

MATERIALS AND METHODS:

In vitro experiments PPIs anti-tumor efficacy in terms of cell proliferation and cell death/apoptosis/necrosis evaluation were performed. In vivo PPIs efficacy experiments were carried out using melanoma xenograft model in SCID mice.

RESULTS:

Lansoprazole showed higher anti-tumor effect when compared to the other PPIs. The lansoprazole effect lasted even upon drug removal from the cell culture medium and it was independent from the lipophilicity of the PPIs formulation.

DISCUSSION:

These PPIs have shown different anti-tumoral efficacy, and the most effective at low dose was lansoprazole.

CONCLUSION:

The possibility to contrast tumor acidity by off-label using PPIs opens a new field of oncology investigation.

 

https://www.ncbi.nlm.nih.gov/pubmed/26018420


Related Articles

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.